Using the Skin Microbiome to Control Atopic Dermatitis

(MedPage Today) -- A topical atopic dermatitis (AD) treatment derived from skin bacteria demonstrated safety and preliminary evidence of clinical activity in a proof-of-principle study.
After seven days of treatment, MSB-0221 significantly reduced...